The efficacy of combined low-doses of propranolol and flunarizine in episodic migraine

This retrospective review is to evaluate the efficacy of a fixed combination of low doses of long - acting propranolol and flunarizine, when flunarizine mono therapy is ineffective in migraine. Thirty- five patients (ages 21-57 years; average 36.5 years; male-female ratio, 1:4) compatible with the diagnosis of migraine without aura received an initial single evening dose of flunarizine of 10 mg for a period of 8 weeks and none of them showed change of migraine attacks per month. These patients were divided into two treatment groups - Group A received a fixed combination of 20 mg. long acting propranolol and 5mg. flunarizine and group B received a fixed combination of 40mg. long acting propranolol and 10mg. flunarizine for a period of 8 weeks, without a "drug-free" period of observation. The patients were assessed at the end of 8 weeks period for differences in attack frequency, duration and intensity compared to the baseline as well as in both the treatment groups. Both groups showed significant reduction in the mean (±SD) of monthly migraine frequency, headache intensity, and headache duration (Wilcoxon Signed Rank test, significant at p<= 0.01) when compared to baseline parameters. However, there was no significant difference in frequency, duration and severity (Mann-Whitney U test, not significant at p<= 0.05) for both doses groups when compared. There was no adverse effect observed. This study suggests that the fixed dose combination of 20 mg propranolol and 5 mg flunarizine could be a new treatment initiative, especially for patients in whom flunarizine mono therapy is ineffective in migraine prophylaxis.

___

1. Holroyd KA, Penzien DB, Rockicki LA, Cordingley GE. Flunarizine versus Propranolol. A meta-analysis of clinical trials. Headache 1992; 32: 256-261.

2. Diener HC. Flunarizine for migraine prophylaxis. In: Diener HD, editor. Drug Treatment of Migraine and Other HeadachesMonographs in Clincal Neuroscience. Vol. 17. Basel: Karger; 2000. pp. 269-278.

3. Vincenzo C, Domenica M, Marcello V, et al. Flunarizine in migraine prophylaxis: efficacy and tolerability of 5 mg and 10 mg dose levels. Cephalalgia 1990; 10: 17-24.

4. Pascual J, Polo JM, Berciano J. The dose of propranolol for migraine prophylaxis. Efficacy of low doses. Cephalalgia 1989: 9: 287-291.

5. Bassi P, Brunati L, Rapuzzi B, Alberti E, Mangoni A. Low dose flunarizine in the prophylaxis of migraine. Headache 1992; 32: 390- 392.

6. Peterlin BL, Calhoun AH, Siegel S, Mathew NT. Rational combination therapy in refractory migraine. Headache 2008; 48: 805-819.

7. Pascual J, Leira R, La´inez JM. Combined therapy for migraine prevention? Clinical experience with a beta-blocker plus sodium valproate in 52 resistant migraine patients. Cephalalgia 2003; 23: 961-962.

8. Krymchantowski AV, Hampshire F. Polytherapy in migraine prevention. Clinical experience with the combination of a tricyclic antidepressant plus a calcium channel blocker. Headache 2004; 44: 499-500.

9. Pascual J, Rivas MT, Leira R. Testing the combination beta blocker plus topiramate in refractory migraine. Acta Neurol Scand 2007; 115: 81-83.

10. Luo N, Di W, Zhang A, et al. A randomized, oneyear clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis. Pain Med 2012; 13: 80-86.

11. Bordini CA, Arruda MA, Cicciarelli MC, Speciali JG. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial. Arq Neuropsiaquiatr 1997; 55: 536-541.

12. Domingues RB, Silva AL, Domingues SA, Aquino CC, Kuster GW. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. Arq. Neuro Psiquiatr 2009; 67: 973-977.

13. Keskinbora K, Aydinli I. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine. Clin Neurol Neurosurg 2007; 110: 979-984.

14. Krymchantowski AV, da Cunha Jevoux C, Bigal ME. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders. J Headache Pain 2012; 13: 53-59.

15. Krymchantowski AV, da Cunha Jevoux C. Lowdose topiramate plus sodium divalproate for positive responders intolerant to full-dose monotherapy. Headache 2012; 52: 129-132.

16. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004; 24 Suppl 1: 9-160.

17. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2004: CD003225.

18. Tvedskov JF, Thomsen LL, Thomsen LL, et al. The effect of propranolol on glyceryltrinitrateinduced headache and arterial response. Cephalalgia 2004; 24: 1076-1087.

19. Pradalier A, Serratrice G, Collard M, et al. Longacting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study. Cephalalgia 1989; 9: 247-253.

20. al-Qassab HK, Findley LJ. Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study. Cephalalgia 1993; 13: 128-131.

21. Anderson KE, Vinge E. Beta-blockers and calcium channel blockers in the prophylaxis and treatment of migraine. Drugs 1990; 39: 355-373.

22. Silberstein S, Freitag FG. Preventive treatment of migraine. Neurology 2003; 60: 38-48.